Impact of time from symptom onset to drug administration on outcome in patients undergoing glycoprotein IIb-IIIa facilitated primary angioplasty (from the EGYPT cooperation).
暂无分享,去创建一个
D. Dudek | M. Noc | K. Huber | G. De Luca | C. Gibson | A. V. Van't Hof | D. Cutlip | U. Zeymer | T. Rakowski | H. Gabriel | A. Emre | M. Maioli | F. Bellandi | S. Zorman | M. Gyongyosi | A. V. Van’t Hof | C. Gibson | A. V. van‘t Hof